Women with obesity and/or diabetes (the population using GLP-1 medications) already face higher pregnancy complication rates even without medication
Description IGF-1 LR3 (Long [Arg] Insulin-like Growth Factor-1) is a recombinant synthetic analog of human insulin-like growth factor 1, engineered with two structural modifications: an arginine substitution replacing glutamate at position 3 of the IGF-1 sequence (reducing IGFBP-3 binding affinity), and a 13-amino-acid N-terminal extension (Long peptide leader)
Polley pointed out that even patients with similar clinical profiles might prioritize different aspects of their health or quality of life
When whole-food protein intake is consistently suppressed by GLP-1 therapy, a free-form EAA supplement can help maintain EAA availability without the caloric load or digestive demand of a full protein shake
Each peptide contributes to a different area of scientific interest, and researchers evaluate combinations based on experimental design rather than expected outcomes
At Midi, we have a range of available solutions to help treat brain fog during menopause, including hormone therapy, lifestyle changes, and supplements like our Daily Brain Boost